IP Library Granted Patent US 8,377,916
Granted Patent B2
US 8,377,916 · App. 13/288,558 · Granted Feb 19, 2013

Steroids as agonists for FXR

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,377,916
App. No.
13/288,558
Granted
Feb 19, 2013
Kind
B2
Abstract

The invention relates to compounds of formula (I): wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists.

Claims (5)

1. A method for the treatment of cholestatic liver disease, atherosclerosis, arteriosclerosis, hypercholesteremia, or hyperlipidemia comprising administering a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I)

or a pharmaceutically acceptable salt or amino acid conjugates thereof, wherein R is ethyl and at least one pharmaceutical carrier or diluent, wherein said compound is administered at 0.01 mg/kg to 100 mg/kg per dose.

2. The method of claim 1 , wherein the composition is administered orally.

3. The method of claim 1 , wherein the composition is administered as a single daily dose.

4. The method of claim 1 , wherein the administration is the compound of formula I

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →
CHANGE OF ADDRESS Recorded Jul 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 060814/0757 →
SECURITY INTEREST Recorded Aug 18, 2021
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 057650/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2011
From: PELLICCIARI, ROBERTO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 027184/0696 →